Gd(III) :

Shouying Cao1, Yaqing Xie1, Xiaotong Lu1

  • 1Department of Pharmaceutical Engineering, Anhui Provincial Key Laboratory of Tumor Evolution and Intelligent Diagnosis and Treatment, Bengbu Medical University, Bengbu 233030, PR China.

PubMed
概括

两种新的加多 (III) 复合物,Gd1和Gd2,用希夫基联体合成,显示出作为抗癌剂的显著潜力. 它们有效地抑制瘤细胞的增殖,迁移,并诱导A549细胞的亡,表现优于西斯.